| Product |
CAS |
Molecular formula |
More |
| β-cyclopentyl-4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-(βr)-1h-pyrazole-1 |
1092939-16-6 |
C17H18N6.H2O4S |
More |
| (3R,4r)-rel-tetrahydro-n-hydroxy-4-[[4-[(2-methyl-4-quinolinyl)methoxy |
1006891-27-5 |
C24H25N3O5 |
More |
| α-amino-n-[5,6-dihydro-2-(1-methyl-1h-pyrazol-4-yl)-6-oxo-1h-pyrrolo[ |
952021-60-2 |
C22H25N7O2 |
More |
| β-cyclopentyl-4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-(βr)-1h-pyrazole-1 |
941678-50-8 |
C17H18N6.C2HF3O2 |
More |
| Rel-2-[4-[[(4r,5s)-4,5-bis(4-chlorophenyl)-2-[4-(1,1-dimethylethyl)-2- |
939983-14-9 |
C40H49Cl2N5O4 |
More |
| Hexahydro-7-[[3-methoxy-4-(4-methyl-1h-imidazol-1-yl)phenyl]methylene] |
937812-80-1 |
C26H24F3N3O3 |
More |
| N-[(1s)-2-[[(5s)-4,5-dihydro-3-methyl-4-oxo-3h-2,3-benzodiazepin-5-yl] |
935525-13-6 |
C21H20F2N4O4 |
More |
| 3,5-Dichloro-n-[[4-fluoro-1-[(tetrahydro-2,2-dimethyl-2h-pyran-4-yl)me |
918431-87-5 |
C21H29Cl2FN2O2 |
More |
| Trans-4-[4-[[[5-[(3,4-difluorophenyl)amino]-1,3,4-oxadiazol-2-yl]carbo |
892489-52-0 |
C23H22F2N4O4 |
More |
| 4-(4-Fluoro-2-hydroxyphenyl)-α-methyl-2,6-bis(1-methylethyl)-5-propyl |
202917-17-7 |
C22H30FNO2 |
More |
| 1-[(4-Chlorophenyl)methyl]-3-[(1,1-dimethylethyl)thio]-α,α-dimethyl- |
147030-01-1 |
C34H35ClN2O3S.Na |
More |
| 1-[(4-Chlorophenyl)methyl]-3-[(1,1-dimethylethyl)thio]-α,α-dimethyl- |
136668-42-3 |
C34H35ClN2O3S |
More |
| N-[4-[2-(3,4-dihydro-6,7-dimethoxy-2(1h)-isoquinolinyl)ethyl]phenyl]-9 |
143851-84-7 |
C34H33N3O5.C4H4O4 |
More |
| Phenyl[4-(4-quinazolinyl)-1-piperazinyl]methanone |
1053655-62-1 |
C19H18N4O |
More |
| 7-(3-Hydroxypropoxy)-4(3h)-quinazolinone |
557770-89-5 |
C11H12N2O3 |
More |
| 6-Chloro-4-cyclopropyl-2(1h)-quinazolinone |
150878-36-7 |
C11H9ClN2O |
More |
| 1-Methyl-1h-pyrrole-3-sulfonyl chloride |
142112-64-9 |
C5H6ClNO2S |
More |
| 6-Bromo-1,4-dioxaspiro[4.6]undecane |
70562-63-9 |
C9H15BrO2 |
More |
| 2-(Dimethylamino)-2-(hydroxymethyl)-1,3-propanediol |
1112-24-9 |
C6H15NO3 |
More |
| 2-(4-Chlorophenyl)-4-thiazoleethanamine |
26858-31-1 |
C11H11ClN2S.HCl |
More |